Background: It is uncertain whether amnioinfusion (infusion of saline into the amniotic cavity) in women who have thick meconium staining of the amniotic fluid reduces the risk of perinatal death, moderate or severe meconium aspiration syndrome, or both.
Methods: We performed a multicenter trial in which 1998 pregnant women in labor at 36 or more weeks of gestation who had thick meconium staining of the amniotic fluid were stratified according to the presence or absence of variable decelerations in fetal heart rate and then randomly assigned to amnioinfusion or to standard care. The composite primary outcome measure was perinatal death, moderate or severe meconium aspiration syndrome, or both.
Results: Perinatal death, moderate or severe meconium aspiration syndrome, or both occurred in 44 infants (4.5 percent) of women in the amnioinfusion group and 35 infants (3.5 percent) of women in the control group (relative risk, 1.26; 95 percent confidence interval, 0.82 to 1.95). Five perinatal deaths occurred in the amnioinfusion group and five in the control group. The rate of cesarean delivery was 31.8 percent in the amnioinfusion group and 29.0 percent in the control group (relative risk, 1.10; 95 percent confidence interval, 0.96 to 1.25).
Conclusions: For women in labor who have thick meconium staining of the amniotic fluid, amnioinfusion did not reduce the risk of moderate or severe meconium aspiration syndrome, perinatal death, or other major maternal or neonatal disorders.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMoa050223 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neonatal meconium aspiration syndrome associated with ABCA3 gene mutation and mycoplasma infection: a case report.
BMC Pediatr
January 2025
Department of Pediatrics II (Neonatology), Medical University of Innsbruck, Innsbruck, Austria.
Preterm infants are at high risk of developing respiratory distress syndrome (RDS). Mutations in the genes encoding for surfactant proteins B and C or the ATP-binding cassette transporter A3 (ABCA3) are rare but known to be associated with severe RDS and interstitial lung diseases. The exact prevalence of these mutations in the general population is difficult to determine, as they are usually studied in connection with clinical symptoms.
View Article and Find Full Text PDFDeterminants of neonatal mortality among hospitalised neonates with sepsis at Queen Elizabeth Central Hospital, Blantyre, Malawi: A mixed-methods study.
PLOS Glob Public Health
December 2024
Department of Health Systems and Policy, Kamuzu University of Health Sciences, Blantyre, Malawi.
Article Synopsis
- The study focuses on neonatal sepsis mortality in Malawi, highlighting the significant health challenge it poses, especially in low-resource settings.
- Researchers utilized both quantitative and qualitative methods to identify risk factors contributing to these deaths and to examine the health system's role in the outcomes.
- Key findings indicated that factors such as gestation age and duration of hospital stay were critical predictors, alongside maternal behaviors and health system limitations that hinder timely treatment and care for affected neonates.
Management and Follow-Up of a Cohort of Neonates With Meconium Aspiration Syndrome Before and After the Revision of the 2015 Neonatal Resuscitation Program.
Cureus
November 2024
Neonatology Department, Unidade Local de Saúde (ULS) de Coimbra, Coimbra, PRT.
Article Synopsis
- - Meconium aspiration syndrome (MAS) is a serious respiratory issue in newborns that can lead to long-term health problems, prompting updates in care standards, particularly the 2015 Neonatal Resuscitation Program (NRP) to improve outcomes.
- - A 15-year study analyzed outcomes for MAS patients before and after the revised NRP, finding increased use of positive pressure ventilation in delivery rooms, but no significant changes in overall morbidity or clinical outcomes, except for improved acidosis and reduced hyperlactatemia.
- - While the updated NRP did not negatively affect clinical outcomes, challenges like cerebral palsy and global development delays remain prevalent, highlighting the ongoing impact of MAS on health even after interventions.
Treprostinil Use in the NICU.
Adv Neonatal Care
December 2024
Author's Affiliation: University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania.
Background: Treprostinil is a prostacyclin analogue that is frequently used in the pediatric and adult population to treat pulmonary hypertension; however, it is not often a drug of choice for patients in the neonatal intensive care unit (NICU).
Purpose: To evaluate the efficacy of treprostinil as a treatment for pulmonary hypertension of the neonate.
Data Sources: Electronic databases such as PubMed, CINAHL, and Embase were used for this literature review.
High-Flow Oscillatory Ventilation: A Possible Therapeutic Option for Pediatric Patients with Cardiovascular Diseases.
Pediatr Rep
October 2024
Department of Anesthesia and Intensive Care 1, Azienda Ospedaliero Universitaria Policlinico, G. Rodolico-San Marco, 95123 Catania, Italy.
Article Synopsis
- High-flow oscillatory ventilation (HFOV) is a vital rescue treatment for infants and children experiencing respiratory failure from various conditions but poses risks for those with congenital heart diseases.
- HFOV operates by delivering small tidal volumes at high frequencies, which can manipulate essential hemodynamic parameters, potentially endangering congenital heart patients.
- Recent studies suggest that HFOV may not significantly impact these hemodynamic factors and can be beneficial for pediatric patients with congenital heart issues, leading to a re-evaluation of its use in this population.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!